Lonza Group AG (0QNO.L) LSE

572.00

-5.8(-1.00%)

Updated at September 08 02:35PM

Currency In CHF

Lonza Group AG

Address

Muenchensteinerstrasse 38

Basel, 4002

Switzerland

Phone

41 61 316 81 11

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

17995

First IPO Date

March 07, 2006

Key Executives

NameTitlePayYear Born
Dr. Wolfgang Wienand Ph.D.Chief Executive Officer01972
Dr. Matthias HofmannHead of Corporate Environment, Health, Safety & Global Sustainability0N/A
Ms. Nicoleta BaumgartnerChief Human Resources Officer01971
Mr. Andreas BohrerGroup General Counsel & Company Secretary0N/A
Mr. Daniel BuchtaHead of Investor Relations0N/A
Mr. Philippe DeeckeChief Financial Officer0N/A
Ms. Kim HarrelsonHead of Ethics & Compliance, ERM and Corporate Responsibility0N/A
Ms. Victoria MorganHead of External Communications0N/A
Ms. Jennifer ClancySenior Director of Global Marketing0N/A
Ms. Maria Soler NunezHead of Group Operations01969

Description

Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions. The Biologics division engages in the contract development and manufacturing services for biopharmaceuticals. The Small Molecules division operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. The Cell and Gene division develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies. It also offers contract development and manufacturing services for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment provides specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules and Health Ingredients division offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.